JPRN-UMIN000052877
Not yet recruiting
未知
The effectiveness of patient reported outcome (PRO) in palliative care units : a cluster randomized controlled trial - The effectiveness of patient reported outcome (PRO) in palliative care units : a cluster randomized controlled trial
Tohoku University Graduate School of Medicine0 sites400 target enrollmentJanuary 24, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Cancer patients admitted to the Palliative Care Unit
- Sponsor
- Tohoku University Graduate School of Medicine
- Enrollment
- 400
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients with obvious disturbance of consciousness. 2\. Patients who the physician or nurse practitioner determines are not appropriate for the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using DuoTrav APS Eye Drops Solution Versus XALACOM® Eye Drops Solution - DuoTrav APS versus XALACOM® in Patient Reported Outcomes and Ocular Surface HealthEUCTR2009-010604-29-BEAlcon Research, Ltd.400
Completed
Phase 3
An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using DuoTrav APS Eye Drops Solution Versus XALACOM® Eye Drops Solution.raised intra-ocular pressure with optic nerve damageraised intra-ocular pressure without optic nerve damage10018307NL-OMON35130Alcon Laboratories30
Active, not recruiting
Not Applicable
An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using Travoprost APS Eye Drops Solution Versus XALATAN Eye Drops Solution - Travoprost APS versus XALATAN in OSDIOpen Angle Glaucoma or Ocular HypertensionMedDRA version: 9.1Level: LLTClassification code 10030043Term: Ocular hypertensionMedDRA version: 9.1Level: LLTClassification code 10030348Term: Open angle glaucomaEUCTR2009-010606-10-GBAlcon Research, Ltd.516
Active, not recruiting
Not Applicable
An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using DuoTrav APS Eye Drops Solution Versus XALACOM® Eye Drops Solution - DuoTrav APS versus XALACOM® in Patient Reported Outcomes and Ocular Surface Healthglaucoma/dry eyeMedDRA version: 9.1Level: LLTClassification code 10030348Term: Open angle glaucomaMedDRA version: 9.1Level: HLGTClassification code 10018307Term: Glaucoma and ocular hypertensionMedDRA version: 9.1Level: LLTClassification code 10030043Term: Ocular hypertensionMedDRA version: 9.1Level: LLTClassification code 10013774Term: Dry eyeEUCTR2009-010604-29-PTAlcon Research, Ltd.400
Active, not recruiting
Not Applicable
An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using Travoprost APS Eye Drops Solution Versus XALATAN Eye Drops Solution - Travoprost APS versus XALATAN® in Patient Reported Outcomes and Ocular Surface HealthEUCTR2009-010606-10-LTAlcon Research, Ltd.516